Amerikanische Gesellschaft für Hirudotherapie

Gene Expression Underlying Teloblast Formation in Leech (Annelida: Hirudinae)

Research article published in Evolutionary bioinformatics online (2026)

Zuletzt aktualisiert: June 18, 2026Geprüft von: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportArzneimittelentwicklungHsiao S et al. · Evolutionary bioinformatics online, 2026

Abstract

OBJECTIVE: Species of glossiphoniid leech provide model systems for exploring fundamental questions in evolutionary and developmental biology. In this study, we took advantage of large embryonic cells and stereotypical cleavage patterns in the leech, Helobdella austinensis, to identify genes associated with the births of teloblasts and their lineage specifications. METHODS: Using staged embryos and pools of dissected precursor cells and teloblasts, a systematic computational comparison of staged and cell type-specific transcriptomic data was employed to identify unique gene sets associated with mesodermal (M), neuroectodermal (N) and teloblast (M + N) cell formation. RESULTS AND CONCLUSIONS: Our predicted candidate genes comprised sets of nucleic acid binding factors as anticipated but displayed little similarity with differentiation factors in other metazoans (eg, mammals, cnidarians), suggesting that stem cell/lineage induction processes have diverged across the Animalia and may reflect fundamentally different modes of embryonic development. Leeches are historically well known for bloodletting practices that were widespread throughout the 19th century and were also a classic preparation for neurobiologists during the same period. In modern times they have found medical applications in reconstructive surgeries, wound healing and more recently “hirudotherapy.” Lesser known are the contributions of leeches to embryology and evolution. Here we take advantage of unusually large embryos in the leech, Helobdella autinensis, to isolate homogeneous populations of teloblasts and their immediate precursor cells. By extracting RNA from these different cells, we were able to identify sets of genes that were unique to each cell type. Computational analyses of targeted genes suggest that many are associated with determining stem cell fate and lineage specification (eg, mesoderm, neuroectoderm). Interestingly, however, our predicted gene sets display only marginal similarity with comparable genes in other animals (eg, humans, Hydra), implying that early developmental processes associated with stem cell formation have diverged considerably over the course of animal evolution.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Zusammenfassung

Gene Expression Underlying Teloblast Formation in Leech (Annelida: Hirudinae).

Warum dies für die Hirudotherapie relevant ist

This study used staged embryos and dissected precursor cells/teloblasts of the leech Helobdella austinensis to identify gene sets associated with mesodermal (M), neuroectodermal (N), and combined teloblast cell formation, finding candidate nucleic acid binding factors with limited similarity to differentiation genes in other metazoans. The authors note leeches' historical role in bloodletting, modern use in reconstructive surgery and wound healing, and recent 'hirudotherapy.' For ASH's domain, the connection is contextual and historical rather than mechanistic: the study concerns leech developmental biology and does not investigate the secretome, hirudin, or clinical hirudotherapy. CAVEAT: This is a basic developmental/transcriptomic study with no data on leech salivary compounds or therapeutic application; relevance to ASH's core domain is indirect and limited to the organismal context.

Zitation

Gene Expression Underlying Teloblast Formation in Leech (Annelida: Hirudinae)

Hsiao S et al. · Evolutionary bioinformatics online, 2026

Verwandter klinischer Kontext

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: June 18, 2026

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.